Mild cognitive impairment clinical trials
- 1 August 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (8) , 646-653
- https://doi.org/10.1038/nrd1155
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?Experimental Gerontology, 2003
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- The Neuropsychiatric InventoryNeurology, 1994
- Aging-Associated Cognitive DeclineInternational Psychogeriatrics, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Amyloid deposition as the central event in the aetiology of Alzheimer's diseaseTrends in Pharmacological Sciences, 1991
- Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work groupDevelopmental Neuropsychology, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982